<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-TSURB8KY</identifier><date>2020</date><creator>Tomašič, Tihomir</creator><relation>documents/doc/T/URN_NBN_SI_doc-TSURB8KY_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TSURB8KY_001.txt</relation><format format_type="issue">2</format><format format_type="volume">71</format><format format_type="type">article</format><format format_type="extent">str. 107-111</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">21000451</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TSURB8KY</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">koronavirus</subject><subject language_type_id="slv">pandemija covid-19</subject><subject language_type_id="slv">Pandemije</subject><subject language_type_id="slv">Virusne infekcije</subject><title>Coronavirus SARS-CoV-2 and covid-19 disease</title><title>Koronavirus SARS-CoV-2 in bolezen covid-19</title></Record>